You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 8, February 28, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Contempo Updates: Linking Evidence and Experience
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Surgical Interventions
 •Cardiovascular/ Cardiothoracic Surgery
 •Vascular Surgery
 •Cardiovascular Intervention
 •Revascularization
 •Alert me on articles by topic

Choice of Revascularization Strategy for Patients With Coronary Artery Disease

René Prêtre, MD; Marko I. Turina, MD

JAMA. 2001;285:992-994.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Surgical coronary artery bypass grafting (CABG) was first performed in 1967 and percutaneous transluminal coronary artery angioplasty (PTCA) in 1977. Initially the 2 revascularization methods appeared complementary: the less invasive PTCA seemed suited for patients with limited lesions, and CABG for those with diffuse disease. The Duke University group, in a large prospective study, first established that PTCA achieved the greatest survival benefit in patients with a single-vessel disease other than proximal left anterior descending (LAD) artery stenosis, and CABG in those with multivessel disease or proximal LAD artery stenosis. Patients with 2-vessel disease or an isolated proximal LAD artery stenosis had similar results with either therapy.1-2 However, individual clinical variables, such as the characteristics of the stenosis, the patient's ventricular function, and associated comorbidities, are often factored into the final decision about the method of revascularization. In the 1990s, a number of . . . [Full Text of this Article]

PTCA vs CABG: The Randomized Trials

Mortality and Recurrent Disease

Other End Points

Recent Developments

Intracoronary Stenting

Minimally Invasive Surgery

Arterial Revascularization

Current Management of Patients With CAD

Author Affiliations: Cardiovascular Surgery, University Hospital, Zürich, Switzerland.


RELATED LETTER

Revascularization Methods for Coronary Artery Disease
Harry W. Donias, Colin J. Powers, Jacob Bergsland, Hratch L. Karamanoukian, René Prêtre, and Marko I. Turina
JAMA. 2001;285(20):2580-2581.
EXTRACT | FULL TEXT  

RELATED ARTICLE

February 28, 2001
JAMA. 2001;285(8):1097-1098.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hybrid Coronary Revascularization in the Era of Drug-Eluting Stents
Murphy et al.
Ann. Thorac. Surg. 2004;78:1861-1867.
ABSTRACT | FULL TEXT  

Clinical outcome after coronary artery revascularization and lung transplantation
Patel et al.
Ann. Thorac. Surg. 2003;75:372-377.
ABSTRACT | FULL TEXT  

Cardiac Surgical Pathology
Schoen and Padera
Card Surg Adult 2003;2:119-185.
FULL TEXT  

Time courses of apoptosis and cell proliferation and their relationship to arterial remodeling and restenosis after angioplasty in an atherosclerotic rabbit model
Durand et al.
J Am Coll Cardiol 2002;39:1680-1685.
ABSTRACT | FULL TEXT  

Revascularization Methods for Coronary Artery Disease
Donias et al.
JAMA 2001;285:2580-2581.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.